AMA awards HMS contract for third party recovery activities Today announced that it turned out awarded a agreement by the Condition of HMS Alabama Medicaid Agency to provide various third party recovery activities, including data fits with commercial and government insurors, commercial and Medicare recoveries, real-time pharmacy price avoidance, subrogation, and credit balance audit services. This contract is certainly for a two-year term, with three additional one-calendar year renewal options.Methods Study Conduct The sponsor, Pfizer, helped to design the analysis and analyze the data. The main academic investigator also designed the scholarly study and wrote the first draft of the manuscript. Data were collected by a contract research organization . All authors attest to the veracity and completeness of the data and data analyses and for the fidelity of the report to the protocol , approved the ultimate version, and made the decision to submit the manuscript for publication. All authors have confidentiality agreements with Pfizer. The study was approved by the institutional review board or independent ethics committee for every center. All patients provided written educated consent. Study Patients Our 8-week multicenter, randomized, double-blind, placebo-controlled trial was conducted at 51 centers in 17 countries from January 2009 through September 2010.